The effectiveness criterion : Balancing efficacy against the risks of weight gainCITROME, Leslie.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 12, pp 12-17, 6 p.Article

Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in TherapyCITROME, Leslie.Advances in therapy. 2013, Vol 30, Num 2, pp 114-126, issn 0741-238X, 13 p.Article

Show me the evidence : Using number needed to treatCITROME, Leslie.Southern medical journal (Birmingham). 2007, Vol 100, Num 9, pp 881-884, issn 0038-4348, 4 p.Article

Weighing the evidence: weight management insights for treating major mental illnessCITROME, Leslie.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 12, 28 p.Serial Issue

New treatments for agitationCITROME, Leslie.Psychiatric quarterly. 2004, Vol 75, Num 3, pp 197-213, issn 0033-2720, 17 p.Article

The psychopharmacology of violence with emphasis on schizophrenia, Part 2: Long-term treatmentCITROME, Leslie.The Journal of clinical psychiatry. 2007, Vol 68, Num 2, pp 331-332, issn 0160-6689, 2 p.Article

Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in TherapyCITROME, Leslie.Advances in therapy. 2013, Vol 30, Num 2, pp 102-113, issn 0741-238X, 12 p.Article

Asenapine review, part II: clinical efficacy, safety and tolerabilityCITROME, Leslie.Expert opinion on drug safety. 2014, Vol 13, Num 6, pp 803-830, issn 1474-0338, 28 p.Article

Number Needed to Treat: What It Is and What It Isn't, and Why Every Clinician Should Know How to Calculate ItCITROME, Leslie.The Journal of clinical psychiatry. 2011, Vol 72, Num 3, pp 412-413, issn 0160-6689, 2 p.Article

Comparison of Intramuscular Ziprasidone, Olanzapine, or Aripiprazole for Agitation : A Quantitative Review of Efficacy and SafetyCITROME, Leslie.The Journal of clinical psychiatry. 2007, Vol 68, Num 12, pp 1876-1885, issn 0160-6689, 10 p.Article

The psychopharmacology of violence with emphasis on schizophrenia, Part 1: Acute treatmentCITROME, Leslie.The Journal of clinical psychiatry. 2007, Vol 68, Num 1, pp 163-164, issn 0160-6689, 2 p.Article

Consensus development conference on antipsychotic drugs and obesity and diabetes : Response to consensus statement. Authors' replyCITROME, Leslie; VOLAVKA, Jan.The Journal of clinical psychiatry. 2005, Vol 66, Num 8, pp 1073-1074, issn 0160-6689, 2 p.Article

Treatment decisions in major mental illness : Weighing the outcomesVREELAND, Betty.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 12, pp 5-11, 7 p.Article

Weight gain with atypical antipsychotics : Evidence and insightsHENDERSON, David C.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 12, pp 18-26, 9 p.Article

Pathways to Aggression in Schizophrenia Affect Results of Treatment : Violence in schizophrenia: Mechanisms, Assessment and TreatmentVOLAVKA, Jan; CITROME, Leslie.Schizophrenia bulletin. 2011, Vol 37, Num 5, pp 921-929, issn 0586-7614, 9 p.Article

Schizoaffective Disorder: A Review of Current Research Themes and Pharmacological ManagementKANTROWITZ, Joshua T; CITROME, Leslie.CNS drugs. 2011, Vol 25, Num 4, pp 317-331, issn 1172-7047, 15 p.Article

Iloperidone: A Clinical OverviewCITROME, Leslie.The Journal of clinical psychiatry. Supplement. 2011, Vol 72, Num 1, pp 19-23, 5 p.Article

Pharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry SettingsCITROME, Leslie; VOLAVKA, Jan.CNS drugs. 2011, Vol 25, Num 12, pp 1009-1021, issn 1172-7047, 13 p.Article

Reducing Inpatient Aggression : Does Paying Attention Pay Off?NOLAN, Karen A; CITROME, Leslie.Psychiatric quarterly. 2008, Vol 79, Num 2, pp 91-95, issn 0033-2720, 5 p.Article

Relationship of atypical antipsychotics with development of diabetes mellitusCITROME, Leslie L; JAFFE, Ari B.The Annals of pharmacotherapy. 2003, Vol 37, Num 12, pp 1849-1857, issn 1060-0280, 9 p.Article

Use of mood stabilizers among patients with schizophrenia, 1994-2001CITROME, Leslie; JAFFE, Ari; LEVINE, Jerome et al.Psychiatric services (Washington, D.C.). 2002, Vol 53, Num 10, issn 1075-2730, p. 1212Article

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidolKRAKOWSKI, Menahem; CZOBOR, Pal; CITROME, Leslie et al.Schizophrenia research. 2009, Vol 110, Num 1-3, pp 95-102, issn 0920-9964, 8 p.Article

The ups and downs of dosing second-generation antipsychoticsCITROME, Leslie; JAFFE, Ari; LEVINE, Jerome et al.Psychiatric services (Washington, D.C.). 2007, Vol 58, Num 1, pp 11-11, issn 1075-2730, 1 p.Article

Placing transdermal selegiline for major depressive disorder into clinical context: Number needed to treat, number needed to harm, and likelihood to be helped or harmedCITROME, Leslie; GOLDBERG, Joseph F; PORTLAND, Kimberly Blanchard et al.Journal of affective disorders. 2013, Vol 151, Num 2, pp 409-417, issn 0165-0327, 9 p.Article

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilitiesCITROME, Leslie; JAFFE, Ari; LEVINE, Jerome et al.Schizophrenia research. 2010, Vol 119, Num 1-3, pp 153-159, issn 0920-9964, 7 p.Article